Abstract
Drugs developed from microbial natural products are in the fundaments of modern pharmaceutical companies. Despite decades of research, all evidences suggest that there must remain many interesting natural molecules with potential therapeutic application yet to be discovered. Any efforts to successfully exploit the chemical diversity of microbial secondary metabolites need to rely heavily on a good understanding of microbial diversity, being the working hypothesis that maximizing biological diversity is the key strategy to maximizing chemical diversity. This chapter presents an overview of diverse topics related with this basic principle, always in relation with the discovery of novel secondary metabolites. The types of microorganisms more frequently used for natural products discovery are briefly reviewed, as well as the differences between terrestrial and marine habitats as sources of bioactive secondary metabolite producers. The concepts about microbial diversity as applied to prokaryotes have evolved in the last years, but recent data suggest the existence of true biogeographic patterns of bacterial diversity, which are also discussed. Special attention is dedicated to the existing strategies to exploit the microbial diversity that is not easy to tackle by conventional approaches. This refers explicitly to the current attempts to isolate and cultivate the previously uncultured bacteria, including the application of high throughput techniques. Likewise, the advances of microbial molecular biology has allowed the development of metagenomic approaches, i.e., the expression of biosynthetic pathways directly obtained from environmental DNA and cloned in a suitable host, as another way of accessing microbial genetic resources. Also, approaches relying on the genomics of metabolite producers are reviewed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Blunt JW, Copp BR, Munro MH, Northcote PT, Prinsep MR (2003) Marine natural products. Nat Prod Rep 20: 1–48
Blunt JW, Copp BR, Munro MH, Northcote PT, Prinsep MR (2004) Marine natural products. Nat Prod Rep 21: 1–49
Blunt JW, Copp BR, Munro MH, Northcote PT, Prinsep MR (2005) Marine natural products. Nat Prod Rep 22: 15–61
Blunt JW, Copp BR, Munro MH, Northcote PT, Prinsep MR (2006) Marine natural products. Nat Prod Rep 23: 26–78
Berdy J (2005) Bioactive microbial metabolites. J Antibiot (Tokyo) 58: 1–26
Ward BB (2002) How many species of prokaryotes are there? Proc Natl Acad Sci USA 99: 10234–10236
Curtis TP, Sloan WT, Scannell JW (2002) Estimating prokaryotic diversity and its limits, Proc Natl Acad Sci USA 99: 10494–10499
Pedros-Alio C (2006) Marine microbial diversity: can it be determined? Trends Microbiol 14: 257–263
Hawksworth DL (1991) The fungal dimension of biodiversity, magnitude, significance and conservation. Mycological Res 95: 641–655
Watve MG, Tickoo R, Jog MM, Bhole BD (2001) How many antibiotics are produced by the genus Streptomyces? Arch Microbiol 176: 386–390
Wang J, Soisson SM, Young K, Shoop W, Kodali S, Galgoci A, Painter R, Parthasarathy G, Tang YS, Cummings R et al (2006) Platensimycin is a selective FabF inhibitor with potent antibiotic properties. Nature 441: 358–361
Bentley SD, Chater KF, Cerdeno-Tarraga AM, Challis GL, Thomson NR, James KD, Harris DE, Quail MA, Kieser H, Harper D et al (2002) Complete genome sequence of the model actinomycete Streptomyces coelicolor A3(2). Nature 417: 141–147
Ikeda H, Ishikawa J, Hanamoto A, Shinose M, Kikuchi H, Shiba T, Sakaki Y, Hattori M, Omura S (2003) Complete genome sequence and comparative analysis of the industrial microorganism Streptomyces avermitilis. Nat Biotechnol 21: 526–531
Dean RA, Talbot NJ, Ebbole DJ, Farman ML, Mitchell TK, Orbach MJ, Thon M, Kulkarni R, Xu JR, Pan H et al (2005) The genome sequence of the rice blast fungus Magnaporthe grisea. Nature 434: 980–986
Zengler K, Paradkar A, Keller M (2005) New methods to access microbial diversity for small molecule discovery. In: L Zhang, AL Demain (eds): Natural products drug discovery and therapeutic medicine. Humana Press, Totowa, New Jersey, 275–293
Pelaez F, Genilloud O (2003) Discovering new drugs from microbial natural products. In: JL Barredo (ed): Microorganisms for health care, foods and enzyme production. Research Signpost, Trivendrum, 1–22
Harvey A (2000) Strategies for discovering drugs from previously unexplored natural products. DrugDiscov Today 5: 294–300
Sielaff H, Christiansen G, Schwecke T (2006) Natural products from cyanobacteria: Exploiting a new source for drug discovery. IDrugs 9: 119–127
Ehrenreich IM, Waterbury JB, Webb EA (2005) Distribution and diversity of natural product genes in marine and freshwater cyanobacterial cultures and genomes. Appl Environ Microbiol 71: 7401–7413
Burja AM, Banaigs B, About-Mansour E, Burgess JG, Wright P (2001) Marine cyanobacteria — a prolific source of natural products. Tetrahedron 57: 9347–9377
Harada K (2004) Production of secondary metabolites by freshwater cyanobacteria. Chem Pharm Bull (Tokyo) 52: 889–899
Simmons TL, Andrianasolo E, McPhail K, Flatt P, Gerwick WH (2005) Marine natural products as anticancer drugs. Mol Cancer Ther 4: 333–342
Gerth K, Pradella S, Perlova O, Beyer S, Muller R (2003) Myxobacteria: proficient producers of novel natural products with various biological activities — past and future biotechnological aspects with the focus on the genus Sorangium. J Biotechnol 106: 233–253
Reichenbach H (2001) Myxobacteria, producers of novel bioactive substances. J Ind Microbiol Biotechnol 27: 149–156
Reichenbach H (1999) The ecology of the myxobacteria. Environ Microbiol 1: 15–21
Gaspari F, Paitan Y, Mainini M, Losi D, Ron EZ, Marinelli F (2005) Myxobacteria isolated in Israel as potential source of new anti-infectives. J Appl Microbiol 98: 429–439
Burja A, Wright P (2003) Look first to nature before invention industrial applications for marine cyanobacteria. SIM News 53: 4–9
Pelaez F (2006) The historical delivery of antibiotics from microbial natural products — can history repeat? Biochem Pharmacol 71: 981–990
Chen XH, Vater J, Piel J, Franke P, Scholz R, Schneider K, Koumoutsi A, Hitzeroth G, Grammel N, Strittmatter AW et al (2006) Structural and functional characterization of three polyketide synthase gene clusters in Bacillus amyloliquefaciens FZB 42. J Bacteriol 188: 4024–4036
Walsh C (2003) Antibiotics actions, origins, resistance. ASP Press, Washington, DC
Shivas RG, Hyde KD (1997) Biodiversity of plant pathogenic fungi in the tropics. In: KD Hyde (ed): Biodiversity of tropical microfungi. Hong Kong University Press, Hong Kong, 47–56
Collado J, Platas G, Pelaez F (2001) Identification of an endophytic Nodulisporium sp from Quercus ilex in central Spain as the anamorph of Biscogniauxia mediterranea by rDNA sequencing analysis and effect of different ecological factors on distribution of the fungus. Mycologia 93: 875–886
Rodrigues KF, Petrini O (1997) Biodiversity of endophytic fungi in tropical regions. In: KD Hyde (eds): Biodiversity of tropical microfungi. Hong Kong University Press, Hong Kong, 57–69
Polishook J, Pelaez F, Platas G, Ondeyka JG, Dombrowski AW, Teran AM (2001) Biogeography and relatedness of Nodulisporium strains producing nodulisporic acid. Mycologia 93: 1125–1137
Martiny JB, Bohannan BJ, Brown JH, Colwell RK, Fuhrman JA, Green JL, Horner-Devine MC, Kane M, Krumins JA, Kuske CR et al (2006) Microbial biogeography: putting micro-organisms on the map. Nat Rev Microbiol 4: 102–112
Fierer N, Jackson RB (2006) The diversity and biogeography of soil bacterial communities. Proc Natl Acad Sci USA 103: 626–631
Finlay BJ (2002) Global dispersal of free-living microbial eukaryote species. Science 296: 1061–1063
Bell T, Ager D, Song JI, Newman JA, Thompson IP, Lilley AK, van der Gast CJ (2005) Larger islands house more bacterial taxa. Science 308: 1884
Zhang L (2005) Integrated approaches for discovering novel drugs from microbial natural products. In: L Zhang, AL Demain (eds): Natural products drug discovery and therapeutic medicine. Humana Press, Totowa, New Jersey, 33–55
Bills GF, Platas G, Pelaez F, Masurekar P (1999) Reclassification of a pneumocandin-producing anamorph, Glea lozoyensis gen et sp nov, previously identified as Zalerion arboricola. Mycol Res 103: 179–192
Pelaez F, Cabello A, Platas G, Diez MT, Gonzalez del Val A, Basilio A, Martan I, Vicente F, Bills GE, Giacobbe RA et al (2000) The discovery of enfumafungin, a novel antifungal compound produced by an endophytic Hormonema species biological activity and taxonomy of the producing organisms. Syst Appl Microbiol 23: 333–343
Basilio A, Justice M, Harris G, Bills G, Collado J, de la Cruz M, Diez MT, Hernandez P, Liberator P, Nielsen Kahn J et al (2006) The discovery of moriniafungin, a novel sordarin derivative produced by Morinia pestalozzioides. BioorgMed Chem 14: 560–566
Bills GF, Dombrowski AW, Pelaez F, Polishook J, An Z (2002) Recent and future discoveries of pharmacologically active metabolites from tropical fungi. In: R Walting, JC Fran-kland, AM Ainsworth, S Isaac, CH Robinson (eds): Tropical mycology. CABI Publishing, CAB International, Wallingford, UK, 165–194
Salituro GM, Pelaez F, Zhang BB (2001) Discovery of a small molecule insulin receptor activator. Recent Prog Horm Res 56: 107–126
Strobel G, Daisy B, Castillo U (2005) Novel natural products from rainforest endophytes. Humana Press, Totowa, New Jersey
Ruibal C, Platas G, Bills GF (2005) Isolation and characterization of melanized fungi from limestone formations in Mallorca. Mycological Prog 4: 23–38
Salazar O, Valverde A, Genilloud O (2006) Real-time PCR for the detection and quantification of geodermatophilaceae from stone samples and identification of new members of the genus Blastococcus. Appl Environ Microbiol 72: 346–352
Gonzalez I, Ayuso-Sacido A, Anderson A, Genilloud O (2005) Actinomycetes isolated from lichens: evaluation of their diversity and detection of biosynthetic gene sequences. FEMS Microbiol Ecol 54: 401–415
Gebhardt K, Schimana J, Muller J, Fiedler HP, Kallenborn HG, Holzenkampfer M, Krastel P, Zeeck A, Vater J, Holtzel A et al (2002) Screening for biologically active metabolites with endosymbiotic bacilli isolated from arthropods. FEMS Microbiol Lett 217: 199–205
Piel J, Hui D, Wen G, Butzke D, Platzer M, Fusetani N, Matsunaga S (2004) Antitumor polyketide biosynthesis by an uncultivated bacterial symbiont of the marine sponge Theonella swinhoei. Proc Natl Acad Sci USA 101: 16222–16227
Schirmer A, Gadkari R, Reeves CD, Ibrahim F, DeLong EF, Hutchinson CR (2005) Metagenomic analysis reveals diverse polyketide synthase gene clusters in microorganisms associated with the marine sponge Discodermia dissoluta. Appl Environ Microbiol 71: 4840–4849
Kohlmeyer K, Kohlmeyer E (1979) Marine mycology. Academic Press, London
Bhaduri P, Mohammad BT, Wright PC (2006) The current status of natural products from marine fungi and their potential as anti-infective agents. J Ind Microbiol Biotechnol 33: 325–337
Fenical W (1993) Chemical studies of marine bacteria: developing a new resource. Chem Rev 93: 1673–1683
Mincer TJ, Jensen PR, Kauffman CA, Fenical W (2002) Widespread and persistent populations of a major new marine actinomycete taxon in ocean sediments. Appl Environ Microbiol 68: 5005–5011
Helmke E, Weyland H (1984) Rhodococcus marinonascens sp nov, an actinomycete from the sea. Int J Syst Bacteriol 34: 127–134
Magarvey NA, Keller JM, Bernan V, Dworkin M, Sherman DH (2004) Isolation and characterization of novel marine-derived actinomycete taxa rich in bioactive metabolites. Appl Environ Microbiol 70: 7520–7529
Jensen PR, Fenical W (2005) New natural-product diversity from marine actinomycetes. In: L Zhang, AL Demain (eds): Natural products drug discovery and therapeutic medicine. Humana Press, Totowa, New Jersey, 315–328
Jensen PR, Mincer TJ, Williams PG, Fenical W (2005) Marine actinomycete diversity and natural product discovery. Antonie Van Leeuwenhoek 87: 43–48
Jensen PR, Gontang E, Mafnas C, Mincer TJ, Fenical W (2005) Culturable marine actinomycete diversity from tropical Pacific Ocean sediments. Environ Microbiol 7: 1039–1048
Kim TK, Garson MJ, Fuerst JA (2005) Marine actinomycetes related to the’ salinospora’ group from the Great Barrier Reef sponge Pseudoceratina clavata. Environ Microbiol 7: 509–518
Williams PG, Buchanan GO, Feling RH, Kauffman CA, Jensen PR, Fenical W (2005) New cytotoxic salinosporamides from the marine Actinomycete Salinispora tropica. J Org Chem 70: 6196–6203
Buchanan GO, Williams PG, Feling RH, Kauffman CA, Jensen PR, Fenical W (2005) Sporolides A and B: structurally unprecedented halogenated macrolides from the marine actinomycete Salinispora tropica. Org Lett 7: 2731–2734
Soria-Mercado IE, Prieto-Davo A, Jensen PR, Fenical W (2005) Antibiotic terpenoid chloro-dihydroquinones from a new marine actinomycete. J Nat Prod 68: 904–910
Kwon HC, Kauffman CA, Jensen PR, Fenical W (2006) Marinomycins A-D, antitumorantibiotics of a new structure class from a marine actinomycete of the recently discovered genus ‘marinispora’. J Am Chem Soc 128: 1622–1632
Kim TK, Hewavitharana AK, Shaw PN, Fuerst JA (2006) Discovery of a new source of rifamycin antibiotics in marine sponge actinobacteria by phylogenetic prediction. Appl Environ Microbiol 72: 2118–2125
Okuda T, Ando K, Bills G (2004) Fungal germplasm for drug discovery and industrial applications In: Z An (ed): Handbook of industrial mycology. Marcel Dekker Inc, New York 123–166
Bills GF, Pelaez F, Polishook J, Diez MT, Harris GH, Clapp WH, Dufresne C, Byrne KM, Nallin-Omstead M, Jenkins RG et al (1994) Distribution of zaragozic acids (squalestatins) among filamentous ascomycetes. Mycol Res 98: 733–739
Vilella D, Sanchez M, Platas G, Salazar O, Genilloud O, Royo I, Cascales C, Martin I, Diez T, Silverman KC et al (2000) Inhibitors of farnesylation of Ras from a microbial natural products screening program. J Ind Microbiol Biotechnol 25: 315–327
Torsvik V, Ovreas L, Thingstad TF (2002) Prokaryotic diversity — magnitude, dynamics, and controlling factors. Science 296: 1064–1066
Torsvik V, Ovreas L (2002) Microbial diversity and function in soil: from genes to ecosystems. Curr Opin Microbiol 5: 240–245
Gans J, Wolinsky M, Dunbar J (2005) Computational improvements reveal great bacterial diversity and high metal toxicity in soil. Science 309: 1387–1390
Hughes JB, Hellmann JJ, Ricketts TH, Bohannan BJ (2001) Counting the uncountable: statistical approaches to estimating microbial diversity. Appl Environ Microbiol 67: 4399–4406
de Vargas C, Norris R, Zaninetti L, Gibb SW, Pawlowski J (1999) Molecular evidence of cryptic speciation in planktonic foraminifers and their relation to oceanic provinces. Proc Natl Acad Sci USA 96: 2864–2868
Keller M, Zengler K (2004) Tapping into microbial diversity. Nat Rev Microbiol 2: 141–150
Janssen PH, Yates PS, Grinton BE, Taylor PM, Sait M (2002) Improved culturability of soil bacteria and isolation in pure culture of novel members of the divisions Acidobacteria, Actinobacteria, Proteobacteria, and Verrucomicrobia. Appl Environ Microbiol 68: 2391–2396
Bruns A, Cypionka H, Overmann J (2002) Cyclic AMP and acyl homoserine lactones increase the cultivation efficiency of heterotrophic bacteria from the central Baltic Sea. Appl Environ Microbiol 68: 3978–3987
Kaeberlein T, Lewis K, Epstein SS (2002) Isolating ‘uncultivable’ microorganisms in pure culture in a simulated natural environment. Science 296: 1127–1129
Ferrari BC, Binnerup SJ, Gillings M (2005) Microcolony cultivation on a soil substrate membrane system selects for previously uncultured soil bacteria. Appl Environ Microbiol 71: 8714–8720
Yap WH, Li X, Soong TW, Davies JE (1996) Genetic diversity of soil microorganisms assessed by analysis of hsp70 (dnaK) sequences. J Ind Microbiol 17: 179–184
Handelsman J, Rondon MR, Brady SF, Clardy J, Goodman RM (1998) Molecular biological access to the chemistry of unknown soil microbes: a new frontier for natural products. Chem Biol 5: R245–249
Rondon MR, August PR, Bettermann AD, Brady SF, Grossman TH, Liles MR, Loiacono KA, Lynch BA, MacNeil IA, Minor C et al (2000) Cloning the soil metagenome: a strategy for accessing the genetic and functional diversity of uncultured microorganisms. Appl Environ Microbiol 66: 2541–2547
Handelsman J (2005) How to find new antibiotics. The Scientist October 10: 20–21
Wang GY, Graziani E, Waters B, Pan W, Li X, McDermott J, Meurer G, Saxena G, Andersen RJ, Davies J (2000) Novel natural products from soil DNA libraries in a streptomycete host. Org Lett 2: 2401–2404
Brady SF, Clardy J (2000) Long-chain N-acyl amino acid antibiotics isolated from heterologously expressed environmental DNA. J Am Chem Soc 122: 12903–12904
Brady SF, Chao CJ, Clardy J (2004) Long-chain N-acyltyrosine synthases from environmental DNA. Appl Environ Microbiol 70: 6865–6870
Brady SF, Chao CJ, Handelsman J, Clardy J (2001) Cloning and heterologous expression of a natural product biosynthetic gene cluster from eDNA. Org Lett 3: 1981–1984
Brady SF, Chao CJ, Clardy J (2002) New natural product families from an environmental DNA (eDNA) gene cluster. J Am Chem Soc 124: 9968–9969
Brady SF, Clardy J (2003) Synthesis of long-chain fatty acid enol esters isolated from an environmental DNA clone. Org Lett 5: 121–124
Brady SF, Clardy J (2004) Palmitoylputrescine, an antibiotic isolated from the heterologous expression of DNA extracted from bromeliad tank water. J Nat Prod 67: 1283–1286
Brady SF, Clardy J (2005) N-acyl derivatives of arginine and tryptophan isolated from environmental DNA expressed in Escherichia coli. Org Lett 7: 3613–3616
Brady SF, Clardy J (2005) Cloning and heterologous expression of isocyanide biosynthetic genes from environmental DNA. Angew Chem IntEdEngl 44: 7063–7065
Brady SF, Clardy J (2005) Systematic investigation of the Escherichia coli metabolome for the biosynthetic origin of an isocyanide carbon atom. Angew Chem Int Ed Engl 44: 7045–7048
Gillespie DE, Brady SF, Bettermann AD, Cianciotto NP, Liles MR, Rondon MR, Clardy J, Goodman RM, Handelsman J (2002) Isolation of antibiotics turbomycin a and B from a metagenomic library of soil microbial DNA. Appl Environ Microbiol 68: 4301–4306
An Z, Harris GH, Zink D, Giacobbe RA, Lu P, Sangari R, Svetnik V, Gunter B, Liaw A, Masurekar P et al (2005) Expression of cosmid-size DNA of slow-growing fungi in Aspergillus nidulans for secondary metabolite screening. In: Z An (ed): Handbook of industrial mycology. Marcel Dekker, New York, 167–186
Button DK, Schut F, Quang P, Martin R, Robertson BR (1993) Viability and isolation of marine bacteria by dilution culture: theory, procedures, and initial results. Appl Environ Microbiol 59: 881–891
Connon SA, Giovannoni SJ (2002) High-throughput methods for culturing microorganisms in very-low-nutrient media yield diverse new marine isolates. Appl Environ Microbiol 68: 3878–3885
Rappe MS, Connon SA, Vergin KL, Giovannoni SJ (2002) Cultivation of the ubiquitous SAR11 marine bacterioplankton clade. Nature 418: 630–633
Bruns A, Hoffelner H, Overmann J (2003) A novel approach for the high throughput cultivation assays and the isolation of planktonic bacteria. FEMS Microbiol Ecol 45: 161–171
Gich F, Schubert K, Bruns A, Hoffelner H, Overmann J (2005) Specific detection, isolation, and characterization of selected, previously uncultured members of the freshwater bacterioplankton community. Appl Environ Microbiol 71: 5908–5919
Zengler K, Toledo G, Rappe M, Elkins J, Mathur EJ, Short JM, Keller M (2002) Cultivating the uncultured. Proc Natl Acad Sci USA 99: 15681–15686
Farnet CM, Zazopoulos E (2005) Improving drug discovery from microorganisms. In: L Zhang L, AL Demain (eds): Natural products drug discovery and therapeutic medicine. Humana Press, Totowa, New Jersey, 95–106
Zazopoulos E, Huang K, Staffa A, Liu W, Bachmann BO, Nonaka K, Ahlert J, Thorson JS, Shen B, Farnet CM (2003) A genomics-guided approach for discovering and expressing cryptic metabolic pathways. Nat Biotechnol 21: 187–190
McAlpine JB, Bachmann BO, Piraee M, Tremblay S, Alarco AM, Zazopoulos E, Farnet CM (2005) Microbial genomics as a guide to drug discovery and structural elucidation: ECO-02301, a novel antifungal agent, as an example. J Nat Prod 68: 493–496
Minas W, Bailey JE, Duetz W (2000) Streptomycetes in micro-cultures: growth, production of secondary metabolites, and storage and retrieval in the 96-well format. Antonie Van Leeuwenhoek 78: 297–305
Duetz WA, Ruedi L, Hermann R, O’Connor K, Buchs J, Witholt B (2000) Methods for intense aeration, growth, storage, and replication of bacterial strains in microtiter plates. Appl Environ Microbiol 66: 2641–2646
Ortholand JY, Ganesan A (2004) Natural products and combinatorial chemistry: back to the future. Curr Opin Chem Biol 8: 271–280
Feher M, Schmidt JM (2003) Property distributions: differences between drugs, natural products, and molecules from combinatorial chemistry. J Chem Inf Comput Sci 43: 218–227
Tosteson MT, Scriven DR, Bharadwaj AK, Kishi Y, Tosteson DC (1995) Interaction of palytoxin with red cells: structure-function studies. Toxicon 33: 799–807
Baryza JL, Brenner SE, Craske ML, Meyer T, Wender PA (2004) Simplified analogs of bryostatin with anticancer activity display greater potency for translocation of PKCdelta-GFP. Chem Biol 11: 1261–1267
Wender PA, Hinkle KW, Koehler MF, Lippa B (1999) The rational design of potential chemotherapeutic agents: synthesis of bryostatin analogues. Med Res Rev 19: 388–407
Davies J (2006) Are antibiotics naturally antibiotics? J Ind Microbiol Biotechnol 33: 496–499
Clardy J, Walsh C (2004) Lessons from natural molecules. Nature 432: 829–837
Singh SB, Barrett JF (2006) Empirical antibacterial drug discovery — foundation in natural products. Biochem Pharmacol 71: 1006–1015
Lipinski CA (2003) Chris Lipinski discusses life and chemistry after the Rule of Five. Drug Discov Today 8: 12–16
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Birkhäuser Verlag, Basel (Switzerland)
About this chapter
Cite this chapter
Singh, S.B., Pelaez, F. (2008). Biodiversity, chemical diversity and drug discovery. In: Petersen, F., Amstutz, R. (eds) Natural Compounds as Drugs Volume I. Progress in Drug Research, vol 65. Birkhäuser Basel. https://doi.org/10.1007/978-3-7643-8117-2_4
Download citation
DOI: https://doi.org/10.1007/978-3-7643-8117-2_4
Publisher Name: Birkhäuser Basel
Print ISBN: 978-3-7643-8098-4
Online ISBN: 978-3-7643-8117-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)